Avonex

Recall | Medicines | 23/10/2019

The marketing authorisation holder informed its customers on October 22, 2019 that following out-of-specification results during manufacturing below mentioned batches are recalled as a precautionary measure. The quality issues during manufacturing may result in potential loss of sterility, container closure integrity and formation of particles.

 

 

 

Name of the medicinal product AVONEX 30 Mikrogramm /0,5 ml Injektionslösung im Fertigpen
Marketing authorisation number(s) EU/1/97/033/005
CIP code 3779225
Marketing authorisation holder Biogen Netherlands B.V.
Batch number(s) 1423865
Expiry date 10/31/2020
Classification of the recall1
Depth of recall Pharmacies
BASG reference number INS-640.001-3009
Email

Further inquiry note